National Eye Institute (NEI): Choroidal Neovascularization trials
The registry lists 11 Choroidal Neovascularization studies with National Eye Institute (NEI) as lead sponsor. 0 are open to participants now and 1 have results posted.
Phase 1 5Phase 2 2Phase 3 2No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular DegenerationCompletedNCT00304954Phase 2Results posted
- High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular DegenerationCompletedNCT00656903
- Genetic Study of Age-Related Macular DegenerationCompletedNCT00357578
- Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal DisordersCompletedNCT00101764Phase 1
- Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular DegenerationCompletedNCT00100009Phase 3
- Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel DisordersCompletedNCT00071227Phase 1
- Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic TherapyCompletedNCT00043680Phase 2
- Identification and Treatment of Feeder Vessels in Macular DegenerationCompletedNCT00018070Phase 1
- Fluocinolone Implant to Treat Macular DegenerationCompletedNCT00008515Phase 1
- Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular DegenerationCompletedNCT00001615Phase 1
- Macular Photocoagulation Study (MPS)Status unknownNCT00000158Phase 3